This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Circius Pharma Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Arash Golshenas: Innovator in Tinnitus Treatment
Introduction
Arash Golshenas is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of medical technology, particularly in the treatment of tinnitus. His innovative approach combines energy transmission with patient care, showcasing his commitment to improving health outcomes.
Latest Patents
Golshenas holds a patent for an "Energy transmitting device and system to monitor and treat tinnitus." This device comprises a first unit that produces energy for treating tinnitus and a second unit designed to secure the first unit against the patient's skin. When in operation, the first unit generates energy based on a suggested treatment, transmitting it to the patient through bone conductivity to alleviate tinnitus symptoms. He has 1 patent in this area.
Career Highlights
Arash Golshenas has dedicated his career to developing innovative solutions in healthcare. His work at Circius Pharma AB reflects his passion for advancing medical technology. His contributions have the potential to transform the way tinnitus is treated, offering new hope to patients suffering from this condition.
Collaborations
Golshenas collaborates with talented professionals in his field, including Peter Arndt and Fredrik Westman. These partnerships enhance the development and implementation of his innovative ideas, fostering a collaborative environment for research and advancement.
Conclusion
Arash Golshenas is a pioneering inventor whose work in tinnitus treatment exemplifies the intersection of technology and healthcare. His innovative energy transmitting device represents a significant advancement in medical treatment, highlighting his dedication to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile